AbbVie (ABBV)

$161.13 6.16 (3.68%)

11:35 EDT ABBV Stock Quote Delayed 30 Minutes

ABBV Stock: Buy for the Yield, Hold for This Other Reason

By Thomas Niel, InvestorPlace Contributor Oct 13, 2023

"Safe harbor" status and a high, growing dividend yield isn't the only thing that's appealing with ABBV stock.

The 3 Best Defensive Stocks for Nervous Investors

3 Dividend Kings Every Investor Should Own to Survive a Market Crash

Retirement Royalty: 3 Dividend Aristocrats for a Steady Income Stream

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 3.63M

Day's Range $160.36 - $167.46

52-Week Range $130.96 - $182.89

Dividend & Yield $5.92 (3.67%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

7 Top Healthcare Stocks That Pay Dividends

By Josh Enomoto, InvestorPlace Contributor Oct 4, 2023

With uncertainty being the dominant theme of the moment, investors should consider healthcare stocks that pay dividends.

Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs

By John Blankenhorn, InvestorPlace Contributor Sep 30, 2023

The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars.

Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher

By Muslim Farooque, InvestorPlace Contributor Sep 26, 2023

With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.

7 Safe and Steady Dividend Stocks to Buy for Volatile Time

By Josh Enomoto, InvestorPlace Contributor Sep 19, 2023

Amid a turbulent market landscape, these companies offer safe dividend stocks, combining robust financials with promising future prospects.

The Top 7 Underrated Dividend Stocks Yielding 3% or More

By Alex Sirois, InvestorPlace Contributor Sep 19, 2023

Investors seeking dependable income and upside should buy these dividend stocks yielding 3% or more, the sooner the better

3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains

By Muslim Farooque, InvestorPlace Contributor Sep 5, 2023

These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances.

The 3 Most Promising Biotech Stocks to Own Now

By Michael Que, InvestorPlace Contributor Aug 31, 2023

These top biotech stock picks with high and leading growth potential are must-owns for investors looking for high upside potential.

Now or Never: 7 Blue-Chip Stocks Offering a Once-in-a-Lifetime Opportunity

By Yiannis Zourmpanos, InvestorPlace Contributor Aug 29, 2023

Seizing a selected group of blue-chip stocks may lead to unparalleled growth for investors.

7 Stocks to Buy for the Rest of 2023

By Muslim Farooque, InvestorPlace Contributor Aug 29, 2023

With the stock market off to a bombastic start, these top stocks for 2023 are worth betting on for the remainder of the year

Late-Summer Steals: 7 Stocks to Buy Before Fall

By Josh Enomoto, InvestorPlace Contributor Aug 28, 2023

With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now.

7 Very Oversold High-Yield Stocks to Buy Right Now

By Josh Enomoto, InvestorPlace Contributor Aug 23, 2023

For speculators wanting to gamble the conservative way, these oversold high-yield stocks to buy may be what you’re looking for.

7 Top Dividend Stocks for Income and Stability

By Thomas Niel, InvestorPlace Contributor Aug 21, 2023

Strong fundamentals and long dividend growth track records make these the top seven dividend stocks to buy.

Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035

By Rich Duprey, InvestorPlace Contributor Aug 17, 2023

As companies naturally continue to expand and the stock market grows, trillion-dollar valuations will be a more common occurrence.

7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now

By Alex Sirois, InvestorPlace Contributor Aug 14, 2023

These shares of blue-chip stocks to buy continue to be attractive for smart investors who value strong firms and steady performance.

7 Dividend Stocks to Buy as Investor Sentiment Falters

By Josh Enomoto, InvestorPlace Contributor Aug 14, 2023

With economic uncertainty rising, investors can ride out the potential storm with these dividend stocks to buy.

3 Pharma Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 11, 2023

Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.

Sell Alert: 3 Healthcare Stocks to Dump ASAP

By Larry Ramer, InvestorPlace Contributor Aug 3, 2023

These healthcare stocks to dump now will continue to be weighed down by legal issues and/or slumping sales.

The 7 Best Dividend Stocks to Protect Your Portfolio From Global Chaos

By Josh Enomoto, InvestorPlace Contributor Jul 24, 2023

With global events only rising in entropy, investors ought to consider these best dividend stocks for portfolio protection.

3 of the Best Dividend Stocks to Buy for Passive Income Growth

By Chris MacDonald, InvestorPlace Contributor Jul 20, 2023

For investors looking to create a meaningful stream of passive income in retirement, these dividends stocks are great options.

7 Fantastic Forever Stocks for Long-Term Lucrative Gains

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2023

These forever stocks to buy offer compelling bull cases for the long-haul, alongside spectacular upside potential.

AbbVie (ABBV)

ABBV Stock: Buy for the Yield, Hold for This Other Reason

The 3 Best Defensive Stocks for Nervous Investors

3 Dividend Kings Every Investor Should Own to Survive a Market Crash

Retirement Royalty: 3 Dividend Aristocrats for a Steady Income Stream

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AbbVie (ABBV)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ABBV Stock Predictions, Articles, and AbbVie News

Subscriber Sign in